Calcitriol reduces the occurrence of acute cellular rejection of liver transplants: A prospective controlled study

Pharmazie

Volumn 68, Issue 10, 2013, Pages 821-826

  Xing, Tonghai ^a   Qiu, Guoqiang ^a   Zhong, Lin ^a   Ling, Lihui ^a   Huang, Li ^a   Peng, Zhihai ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; CD4 ANTIGEN; CD45RA ANTIGEN; CYCLOSPORIN; GLUCONATE CALCIUM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLACEBO; RAPAMYCIN; TACROLIMUS; VITAMIN D;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CELLS; CONTROLLED STUDY; FEMALE; FLOW; FLOW CYTOMETRY; GRAFT RECIPIENT; HUMAN; LIVER GRAFT; LIVER GRAFT REJECTION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE SUBPOPULATION; VITAMIN BLOOD LEVEL;

ADULT; AGED; CALCITRIOL; CALCIUM CHANNEL AGONISTS; CD4-POSITIVE T-LYMPHOCYTES; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; GRAFT REJECTION; HUMANS; HYDROXYCHOLECALCIFEROLS; IMMUNOSUPPRESSIVE AGENTS; INTERNATIONAL NORMALIZED RATIO; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84885461759     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2013.3561     Document Type: Article

References (21)

1. Bitetto D, Fabris C, Falleti E, Fornasiere E, Fumolo E, Fontanini E, Cussigh A, Occhino G, Baccarani U, Pirisi M, Toniutto P (2010) Vitamin D and the risk of acute allograft rejection following human liver transplantation. Liver Int 30: 417-444.
2. Briffa NK, Keogh AM, Sambrook PN, Eisman JA.(2003) Reduction of immunosuppressant therapy requirement in heart transplantation by calcitriol. Transplantation 75: 2133-2134. (Pubitemid 36793306)
3. Calne R (2004) Prope tolerance-the future of organ transplantation from the laboratory to the clinic. Transplant Immunol 13: 83-86.
4. Demetris A (1995) Terminology for hepatic allograft rejection. Hepatology 22: 648-654.
5. Demetris A, Ruppert K, Dvorchik I, Jain A, Minervini M, Nalesnik MA, Randhawa P,Wu T, Zeevi A, Abu-Elmagd K, Eghtesad B, Fontes P, Cacciarelli T, Marsh W, Geller D, Fung JJ (2002) Real-time monitoring of acute liver-allograft rejection using the Banff schema1. Transplantation 74: 1290-1296. (Pubitemid 35402600)
6. Dousset B, Conti F, Cherruau B, Louvel A, Soubrane O, Houssin D, Calmus Y (1998) Is acute rejection deleterious to long-term allograft function? J Hepatol 29: 660-668. (Pubitemid 28484957)
7. Dresske B, Zavazava N, Huang D, Lin X, Kremer B, Fändrich F (1998) WOFIE augments the immunosuppressive potency of FK-506. Transplant Immunol 6: 243-249. (Pubitemid 29103682)
8. Farkas SA, Schnitzbauer AA, Kirchner G, Obed A, Banas B, Schlitt HJ (2009) Calcineurin inhibitor minimization protocols in liver transplantation. Transplant Int 22: 49-60.
9. Fisher LR, Henley KS, LuceyMR (1995) Acute cellular rejection after liver transplantation: variability, morbidity, and mortality. Liver Transpl Surg 1: 10-15.
10. Geissler EK, SchlittHJ (2009) Immunosuppression for liver transplantation. Gut 58: 452-463.
11. Liu Z, Yuan X, Luo Y, He Y, Jiang Y, Chen ZK, Sun E (2009) Evaluating the effects of immunosuppressants on human immunity using cytokine profiles of whole blood. Cytokine 45: 141-147.
12. Mantel PY, Ouaked N, Rückert B, Karagiannidis C, Welz R, Blaser K, Schmidt-Weber CB (2006) Molecular mechanisms underlying FOXP3 induction in human T cells. J Immunol 176: 3593-3602. (Pubitemid 43364007)
13. Margarit C, Rimola A, Gonzalez-Pinto I, Cuervas-Mons V, Edo A, Andreu H, Moreno-Gonzalez E, Calleja JL (1998) Efficacy and safety of oral low-dose tacrolimus treatment in liver transplantation. Transplant Int 11: 260-266.
14. Rejection (1997) Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 25: 658-663.
15. Sánchez-Fueyo A, Strom TB (2011) Immunologic basis of graft rejection and tolerance following transplantation of liver or other solid organs. Gastroenterology 140: 51-64.
16. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of selftolerance causes various autoimmune diseases. J Immunol 155: 1151-1164.
17. Shane E, Addesso V, Namerow PB, McMahon DJ, Lo SH, Staron RB, Zucker M, Pardi S, Maybaum S, Mancini D (2004) Alendronate versus calcitriol for the prevention of bone loss after cardiac transplantation. New Engl J Med 350: 767-776. (Pubitemid 38209646)
18. Tanaci N, Karakose H, Guvener N, Tutuncu N, Colak T, Haberal M (2003) Influence of 1, 25-dihydroxyvitamin D3 as an immunomodulator in renal transplant recipients: a retrospective cohort study. Paper presented at the Transplantation proceedings. Transplant Proc 35: 2885-2887. (Pubitemid 38102080)
19. Voo KS,Wang YH, Santori FR, Boggiano C, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ (2009) Identification of IL-17-producing FOXP3 + regulatory T cells in humans. Proc Nat Acad Sci 106: 4793-4798.
20. Wagner D, Amrein K, Dimai HP, Kniepeiss D, Tscheliessnigg KH,Kornprat P, Dobnig H, Pieber T, Fahrleitner-Pammer A (2012) Ibandronate and calcitriol reduces fracture risk, reverses bone loss, and normalizes bone turnover after lTX. Transplantation 93: 331-336.
21. Wieërs G, Gras J, Bourdeaux C, Truong DQ, Latinne D, Reding R (2007) Monitoring tolerance after human liver transplantation. Transplant Immunol 17: 83-93.